{"DataElement":{"publicId":"5434015","version":"1","preferredName":"Primary Adenocarcinoma Differentiation Type","preferredDefinition":"The group based on the cellular characteristic of the primary growth pattern of malignant glandular cells.","longName":"PRI_ADENO_DIFF_TP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"5434014","version":"1","preferredName":"Primary Adenocarcinoma Cellular Differentiation","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value._A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma._In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"5434011v1.0:5434012v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"5434011","version":"1","preferredName":"Primary Adenocarcinoma","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.:A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","longName":"C25251:C2852","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B2B5731-F5B3-DAC9-E050-BB89AD435C57","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"ONEDATA","dateModified":"2016-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2200802","version":"1","preferredName":"Differentiation","preferredDefinition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","longName":"C18314","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Differentiation","conceptCode":"C18314","definition":"In cancer, refers to how mature (developed) the cancer cells are in a tumor. Differentiated tumor cells resemble normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells, which lack the structure and function of normal cells and grow uncontrollably.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F169098A-EBC6-306E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-08","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B2B5731-F5D5-DAC9-E050-BB89AD435C57","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"KNABLEJ","dateModified":"2019-04-25","changeDescription":"4/25/19 jk released/qualified per review by Sarah M.   6/11/18 jk added application status. 8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5427574","version":"1","preferredName":"Adenocarcinoma Type","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma._Something distinguishable as an identifiable class based on common qualities.","longName":"5427574v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Acinar","valueDescription":"Acinar Cell Carcinoma","ValueMeaning":{"publicId":"2558157","version":"1","preferredName":"Acinar Cell Carcinoma","longName":"2558157","preferredDefinition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Carcinoma","conceptCode":"C3768","definition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B03A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-54AF-3AB2-E053-F662850AB7ED","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Lepidic","valueDescription":"Lepidic Predominant Adenocarcinoma","ValueMeaning":{"publicId":"5427576","version":"1","preferredName":"Lepidic Predominant Adenocarcinoma","longName":"5427576","preferredDefinition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lepidic Adenocarcinoma","conceptCode":"C123160","definition":"A lung adenocarcinoma characterized by the presence of mildly and moderately differentiated adenocarcinoma cells across the alveolar walls with at least one focus of invasive carcinoma measuring more than 5 mm in greatest dimension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E0F70-7B3F-007D-E050-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-54C3-3AB2-E053-F662850AB7ED","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Micropapillary","valueDescription":"Micropapillary Serous Carcinoma","ValueMeaning":{"publicId":"5427575","version":"1","preferredName":"Micropapillary Serous Carcinoma","longName":"5427575","preferredDefinition":"An adenocarcinoma characterized by the presence of complex micropapillary structures covered by round and cuboidal cells with a high nuclear to cytoplasmic ratio.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Micropapillary Serous Carcinoma","conceptCode":"C6882","definition":"An adenocarcinoma usually arising from the ovary. It is characterized by the presence of complex micropapillary structures covered by round and cuboidal cells with a high nuclear to cytoplasmic ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E0F70-7AF2-007D-E050-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-54D7-3AB2-E053-F662850AB7ED","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Papillary","valueDescription":"Papillary Adenocarcinoma","ValueMeaning":{"publicId":"3251702","version":"1","preferredName":"Papillary Adenocarcinoma","longName":"3251702","preferredDefinition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Adenocarcinoma","conceptCode":"C2853","definition":"A morphologic variant of adenocarcinoma. It is characterized by the presence of a papillary growth pattern. Representative examples include thyroid gland papillary carcinoma, invasive papillary breast carcinoma, and ovarian serous surface papillary adenocarcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7696A98-D53F-85AE-E040-BB89AD433885","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-54EB-3AB2-E053-F662850AB7ED","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Enteric adenocarcinoma","valueDescription":"Lung Enteric Adenocarcinoma","ValueMeaning":{"publicId":"6077904","version":"1","preferredName":"Lung Enteric Adenocarcinoma","longName":"6077904","preferredDefinition":"A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Enteric Adenocarcinoma","conceptCode":"C136710","definition":"A well-differentiated adenocarcinoma located in the lung periphery. It resembles colorectal adenocarcinoma with acinar and/or cribriform architecture and papillotubular structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65BDFB8B-02BF-31AA-E053-F662850AA84C","latestVersionIndicator":"Yes","beginDate":"2018-02-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-21","modifiedBy":"ONEDATA","dateModified":"2018-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-5440-3AB2-E053-F662850AB7ED","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Fetal adenocarcinoma","valueDescription":"Fetal Adenocarcinoma","ValueMeaning":{"publicId":"3081858","version":"1","preferredName":"Fetal Adenocarcinoma","longName":"3081858","preferredDefinition":"A very rare, well differentiated morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Fetal Adenocarcinoma","conceptCode":"C45509","definition":"A rare morphologic variant of lung adenocarcinoma characterized by the presence of glandular structures containing glycogen-rich cells forming tubules that resemble fetal lung tubules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-479C-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-5455-3AB2-E053-F662850AB7ED","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Colloid adenocarcinoma","valueDescription":"Lung Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"5210947","version":"1","preferredName":"Lung Mucinous Adenocarcinoma","longName":"5210947","preferredDefinition":"A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Colloid Adenocarcinoma","conceptCode":"C45512","definition":"A morphologic variant of lung adenocarcinoma characterized by the presence of mucin pools containing islands of well differentiated adenocarcinoma cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C843-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-5460-3AB2-E053-F662850AB7ED","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Invasive mucinous adenocarcinoma","valueDescription":"Invasive Lung Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"6689664","version":"1","preferredName":"Invasive Lung Mucinous Adenocarcinoma","longName":"6689664","preferredDefinition":"An invasive adenocarcinoma that arises from the lung. It is characterized by the presence of tall columnar cells and mucin production. This category refers to cases formerly classified as mucinous bronchioloalveolar carcinoma, excluding cases that meet the criteria for adenocarcinoma in situ or mucinous minimally invasive adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Lung Mucinous Adenocarcinoma","conceptCode":"C136709","definition":"An invasive adenocarcinoma that arises from the lung. It is characterized by the presence of tall columnar cells and mucin production. This category refers to cases formerly classified as mucinous bronchioloalveolar carcinoma, excluding cases that meet the criteria for adenocarcinoma in situ or mucinous minimally invasive adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8632A34B-546E-3AB2-E053-F662850AB7ED","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-5487-3AB2-E053-F662850AB7ED","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Solid","valueDescription":"Solid Lung Adenocarcinoma with Mucin Production","ValueMeaning":{"publicId":"5210941","version":"1","preferredName":"Solid Lung Adenocarcinoma with Mucin Production","longName":"5210941","preferredDefinition":"A morphologic variant of lung adenocarcinoma characterized by the presence of polygonal malignant cells forming sheets. Acinar, papillary, micropapillary, or lepidic growth patterns are absent.  If the tumor is 100 percent solid, intracellular mucin should be present in at least five tumor cells in each of two high-power fields and confirmed with mucin immunohistochemical stains. Tumors formerly classified as large cell carcinomas expressing pneumocyte immunohistochemical markers, even if intracellular mucin is absent, are now included in this category.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Lung Adenocarcinoma","conceptCode":"C5651","definition":"A morphologic variant of lung adenocarcinoma characterized by the presence of polygonal malignant cells forming sheets. Acinar, papillary, micropapillary, or lepidic growth patterns are absent.  If the tumor is 100 percent solid, intracellular mucin should be present in at least five tumor cells in each of two high-power fields and confirmed with mucin immunohistochemical stains. Tumors formerly classified as large cell carcinomas expressing pneumocyte immunohistochemical markers, even if intracellular mucin is absent, are now included in this category.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC1F18F-C7BC-E402-E050-BB89AD436C18","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"KNABLEJ","dateModified":"2019-04-22","changeDescription":"4/22/19 jk Updated definition to match current NCIt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8632A34B-549B-3AB2-E053-F662850AB7ED","beginDate":"2019-04-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","deletedIndicator":"No"},{"value":"Not specified","valueDescription":"Unspecified","ValueMeaning":{"publicId":"5697867","version":"1","preferredName":"Unspecified","longName":"5697867","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A23568A-7798-5975-E053-F662850A8E6C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB6E005A-A5A9-2A88-E053-4EBD850AF426","beginDate":"2021-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-07","modifiedBy":"ONEDATA","dateModified":"2021-09-07","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CB6E005A-A5B4-2A88-E053-4EBD850AF426","beginDate":"2021-09-07","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-07","modifiedBy":"ONEDATA","dateModified":"2021-09-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5427573","version":"1","preferredName":"Adenocarcinoma Type","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.:Something distinguishable as an identifiable class based on common qualities.","longName":"C2852:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E0F70-7AB6-007D-E050-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"ONEDATA","dateModified":"2016-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3A9E0F70-7AC7-007D-E050-BB89AD436985","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"COLBERTM","dateModified":"2021-09-07","changeDescription":"9/7/21 mr Added NA and Not specified per MCL DD.  4/25/19 jk released/qualified per review by Sarah M. 4/10/19 jk added PVs for PCA-Lung.  6/11/18 jk added application status. 8/21/16 created for MCL Lung data set. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506111","version":"1","longName":"Lung","context":"MCL","ClassificationSchemeItems":[{"publicId":"5858017","version":"1","longName":"Lung Core","context":"MCL"},{"publicId":"7781146","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]},{"publicId":"5506115","version":"1","longName":"Imaging","context":"MCL","ClassificationSchemeItems":[{"publicId":"5983666","version":"1","longName":"Vanderbilt Image Archive","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855641","version":"1","longName":"Lung Pathology","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001792","version":"1","longName":"Lung PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"5434014v1.0:5427574v1.0","type":"System-Generated","context":"MCL"},{"name":"primary_adenocarcinoma_differentiation_type","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Predominant ADC","type":"Preferred Question Text","description":"Predominant ADC","url":null,"context":"MCL"},{"name":"MCL V-Lung","type":"Alternate Question Text","description":"Differentiation of primary tumor (ADC)","url":null,"context":"MCL"},{"name":"MCL-PCA-Lung-1","type":"Alternate Question Text","description":"Primary adenocarcinoma differentiation type","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"lung_v0_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3B2B5731-F5F2-DAC9-E050-BB89AD435C57","latestVersionIndicator":"Yes","beginDate":"2016-08-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-28","modifiedBy":"COLBERTM","dateModified":"2021-09-13","changeDescription":"9/7/21 mr Updated PVs, Classified in Lung Core. 9/1/21 mr Added Alt Name, AQT, ref doc per MCL DD. Classified in PCA Lung.  4/25/19 jk released/qualified per review by Sarah M.  4/10/19 jk upd PQT per email; add prior as AQT.  8/7/18 LS updated to text short name. 8/28/16 jk created for MCL V-Lung content.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}